A possible noninvasive method for the detection of bladder cancer in patients: Microsatellite analysis of free DNA in urine and blood

Annals of the New York Academy of Sciences

Volumn 945, Issue , 2001, Pages 31-35

  Utting, Michael ^a,b   Werner, Wolfram ^a   Müller, Gabriele ^a   Schubert, Jörg ^a   Junker, Kerstin ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b NONE   (Germany)

Author keywords

Bladder cancer; Free DNA; Loss of heterozygosity; Microsatellite alteration

Indexed keywords

DNA; MICROSATELLITE DNA;

ADULT; AGED; BLADDER CANCER; BLOOD; BODY FLUID; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; TRANSURETHRAL RESECTION; URINALYSIS; URINARY TRACT CANCER;

EID: 0034748685     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03861.x     Document Type: Conference Paper

References (11)

1. Urinary cytology and bladder cancer
2. Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy
3. Mutator phenotype may be required for carcinogens
4. Microsatellite alterations as clonal markers for the detection of human cancer
5. Molecular detection of primary bladder cancer by microsatellite analysis
6. Determination of circulating DNA levels in patients with benign or malignant tumors
7. Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients
8. Detection of bladder cancer recurrence by microsatellite analysis of urine
9. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma
10. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer
11. Detection of tumor genetic alterations of bladder carcinomas in body fluids depends on sample treatment before DNA isolation